Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension

Trial ID or NCT#

NCT02250651

Status

not recruiting iconNOT RECRUITING

Purpose

This study will evaluate the efficacy and safety of bimatoprost sustained-release (SR) in patients with open-angle glaucoma or ocular hypertension. The study includes a 12-month treatment period with an 8-month extended follow-up.

Official Title

The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension

Eligibility Criteria

Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Show Less

Investigator(s)

Ann Caroline Fisher, MD
Ann Caroline Fisher, MD
Glaucoma specialist, Cataract specialist
Clinical Professor, Ophthalmology

Contact us to find out if this trial is right for you.

Contact

Mariana Nunez
650-724-3734

View on ClinicalTrials.gov